Table 1

Characteristics of HTLV-1–infected patients and healthy uninfected controls

Patient characteristicHAM/TSP n = 72HVCs n = 96HCs n = 20
Age, y, mean ± SE 55.9 ± 1.6 51.1 ± 1.2 55.2 ± 1.9 
Sex    
    Male 27 51 13 
    Female 45 45 
Serum anti–HTLV-I antibody titer*    
    Mean ± SE 36 932 ± 8414 2106 ± 990 N/A 
    Median 16 348 1024 N/A 
HTLV-I provirus load in PBMCs    
    Mean ± SE 793.2 ± 677 245.0 ± 381 N/A 
    Median 537.0 109.0 N/A 
Patient characteristicHAM/TSP n = 72HVCs n = 96HCs n = 20
Age, y, mean ± SE 55.9 ± 1.6 51.1 ± 1.2 55.2 ± 1.9 
Sex    
    Male 27 51 13 
    Female 45 45 
Serum anti–HTLV-I antibody titer*    
    Mean ± SE 36 932 ± 8414 2106 ± 990 N/A 
    Median 16 348 1024 N/A 
HTLV-I provirus load in PBMCs    
    Mean ± SE 793.2 ± 677 245.0 ± 381 N/A 
    Median 537.0 109.0 N/A 

HVCs indicates HTLV-1 carriers; HCs, uninfected healthy controls; N/A, not applicable.

*

Anti–HTLV-1 antibodies were titrated by the particle agglutination method.

HTLV-1 tax copy number per 104 PBMCs.

Close Modal

or Create an Account

Close Modal
Close Modal